Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA (Q34544953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

title

Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

0 references

Xing-Lei Qin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Zhuo-Ren Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Jing-Sen Shi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Min Lu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Lin Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Quan-Ru He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

language of work or name

English

0 references

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Gastroenterology

18 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

427-432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis

18 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

A clinical evaluation of serological diagnosis for pancreatic cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Establishment and characterization of human hilar bile duct carcinoma cell line and cell strain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Biliary CA 19-9 values correlate with the risk of hepatic metastases in patients with adenocarcinoma of the pancreas

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

A clinical study of 130 patients with biliary tract cancers and periampullary tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Second cancer during long-term survival after resection of biliary tract carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Cytodiagnosis in the management of extrahepatic biliary stricture

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

A prospective controlled study comparing brush and bile exfoliative cytology for diagnosing bile duct strictures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Value of exfoliative cytology for investigating bile duct strictures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Colorectal carcinoma antigens detected by hybridoma antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Extrahepatic bile duct stricture and elevated CA 19-9: malignant or benign?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Combined hepatocellular carcinoma and cholangiocarcinoma growing into the common bile duct

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4724921

Prognostic value of CA 19-9 serum course in pancreatic cancer

27 October 2018

1 reference

12 December 2020

Mirizzi's syndrome with a high CA19-9 level mimicking cholangiocarcinoma

1 reference

12 December 2020

Treatment of tumors of the pancreatic head with suspected but unproved malignancy: is a nihilistic approach justified?

1 reference

12 December 2020

False elevation of CA 19-9 levels in a patient with a history of pancreatic cancer

1 reference

12 December 2020

The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis

1 reference

12 December 2020

A case of inflammatory pseudotumor of the liver causing elevated serum CA19-9 levels

1 reference

12 December 2020

CA 19-9 production by a cystadenoma with mesenchymal stroma of the common hepatic duct: a case report

1 reference

12 December 2020

Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site

1 reference

12 December 2020

Hepatobiliary cystadenocarcinoma without ovarian stroma and normal CA 19-9 levels. Unusually prolonged evolution

1 reference

12 December 2020

Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology

1 reference

12 December 2020

Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study

1 reference

12 December 2020

A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Diagnosis of pancreatic cancer and prediction of unresectability using the tumor-associated antigen CA19-9

1 reference

12 December 2020

CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients

1 reference

12 December 2020

Prognostic factors of intrahepatic cholangiocarcinoma after surgical treatment

1 reference

12 December 2020

Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer

1 reference

12 December 2020

Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts

1 reference

12 December 2020

Carcinosarcoma of the ampulla of Vater: a case report with immunohistochemical and ultrastructural studies

1 reference

12 December 2020

Adenosquamous cell carcinoma arising from the papilla major

1 reference

12 December 2020

Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma

1 reference

12 December 2020

Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

12 December 2020

Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis

1 reference

12 December 2020

Brush cytology during ERCP for the diagnosis of biliary and pancreatic malignancies

1 reference

12 December 2020

A case report of disseminated recurrence of inferior bile duct carcinoma in PTCD fistula

1 reference

12 December 2020

Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers

1 reference

12 December 2020

An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19

1 reference

12 December 2020

High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas

1 reference

12 December 2020

Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis

1 reference

12 December 2020

Clinicopathologic study on cholangiolocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V10.I3.427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14760772%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference